Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New app helps diabetics remember insulin doses

NCT ID NCT05893797

First seen Nov 11, 2025 · Last updated May 01, 2026 · Updated 19 times

Summary

This study tested a connected insulin management platform in 36 people with type 1 or type 2 diabetes who use insulin. The goal was to see if the platform helps them remember insulin doses and keep blood sugar in a healthy range. Participants used a continuous glucose monitor and the platform to track their insulin use and glucose levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU - l'Assistance Publique - Hôpitaux de Marseille

    Marseille, 13005, France

  • CHU Strasbourg-Hautepierre

    Strasbourg, Alsace, 67098, France

  • CHU de Besancon Hopital Jean Minjoz

    Besançon, 25030, France

  • CHU de Caen Hôpital Cote de Nacre

    Caen, Cedex 9, 14033, France

  • CHU de Lyon

    Lyon, 69008, France

  • Centre Hospitalier Sud Francilien-Pharmacie

    Corbeil-Essonnes, 91100, France

  • Centre Hospitalier Universitaire de Nice - Hôpital l'Archet

    Nice, 6202, France

  • Chu de Grenoble

    Grenoble Cédex 9, 38043, France

  • Groupe Hospitalier Mutualiste Les Portes du Sud

    Vénissieux, 69200, France

Conditions

Explore the condition pages connected to this study.